Effect of fibronectin on the binding of antithrombin III to immobilized heparin.
An objective of this research is to verify the mechanism of anticoagulant activity of surface-immobilized heparin in the presence of plasma proteins. The competition and binding interaction between immobilized heparin and antithrombin III (ATIII)/thrombin have been described in vitro. However, the strong ionic character of heparin leads to its specific and nonspecific binding with many other plasma proteins. Most notably, fibronectin contains six active binding sites for heparin which may interfere with the subsequent binding of heparin with ATIII or thrombin. Heparin was covalently immobilized through polyethylene oxide (PEO) hydrophilic spacer groups onto a model surface synthesized by random copolymerization of styrene and p-aminostyrene. The binding interaction of immobilized heparin with ATIII was then determined in the presence of different fibronectin concentrations. The binding interaction was studied by first binding immobilized heparin with ATIII, followed by the introduction of fibronectin; heparin binding with fibronectin, followed by incubation with ATIII, and simultaneous incubation of surface immobilized heparin with ATIII and fibronectin. The extent of ATIII binding to heparin in each experiment was assayed using a chromogenic substrate for ATIII, S-2238. The results of this study demonstrate that the displacement of ATIII from immobilized heparin was proportional to the fibronectin concentration, and was reversible. Furthermore, the binding sequence did not play a role in the final concentration of ATIII bound to immobilized heparin.
Byun
Y
Y
Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City 84112, USA.
Jacobs
H A
HA
Feijen
J
J
Kim
S W
SW
D000925:Anticoagulants / Q000494:pharmacology; D000990:Antithrombin III / Q000378:metabolism*; D001798:Blood Proteins / Q000378:metabolism; D005353:Fibronectins / Q000302:isolation & purification / Q000494:pharmacology*; D005898:Glass; D006487:Hemostasis / Q000187:drug effects; D006493:Heparin / Q000378:metabolism*; D006801:Humans; D011485:Protein Binding; D012996:Solutions; D013997:Time Factors
D000925:Anticoagulants; D001798:Blood Proteins; D005353:Fibronectins; D012996:Solutions; D000990:Antithrombin III; D006493:Heparin